LU504233B1 - A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method Thereof - Google Patents
A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method Thereof Download PDFInfo
- Publication number
- LU504233B1 LU504233B1 LU504233A LU504233A LU504233B1 LU 504233 B1 LU504233 B1 LU 504233B1 LU 504233 A LU504233 A LU 504233A LU 504233 A LU504233 A LU 504233A LU 504233 B1 LU504233 B1 LU 504233B1
- Authority
- LU
- Luxembourg
- Prior art keywords
- liver
- alcohol
- tea
- parts
- extraction
- Prior art date
Links
- 230000002075 anti-alcohol Effects 0.000 title claims abstract description 39
- 230000000694 effects Effects 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 40
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 32
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 32
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 32
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 32
- 241000218231 Moraceae Species 0.000 claims abstract description 26
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims abstract description 5
- 241001122767 Theaceae Species 0.000 claims description 56
- 241000723353 Chrysanthemum Species 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000001223 reverse osmosis Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 3
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 241000252212 Danio rerio Species 0.000 description 19
- 239000003814 drug Substances 0.000 description 10
- 230000009286 beneficial effect Effects 0.000 description 9
- 208000010706 fatty liver disease Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 8
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102000011759 adducin Human genes 0.000 description 3
- 108010076723 adducin Proteins 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000012733 comparative method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229930183392 hovenin Natural products 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a tea drink with anti-alcohol and liver-protecting effects, which belongs to the technical field of health care products, and comprises the following raw materials in parts by weight: 3-4 parts of Hovenia dulcis, 1-2 parts of Pueraria lobata, 1-2 parts of mulberries (Fructus Mori), 1-2 parts of chrysanthemum (chrysanthemum morifolium), 1-2 parts of Pericarpium citri reticulatae and 1-3 parts of Pu-er ripe tea. The preparation method comprises the following steps: weighing the raw materials; mixing Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae, and Pu-er ripe tea, placing in an extraction tank, adding hot water for extraction, and then adding mulberries for continuous extraction to obtain a mixture; Centrifuging the mixture, collecting supernatant, concentrating, and drying to obtain tea.
Description
DESCRIPTION LUS04233
A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method
Thereof
The invention belongs to the technical field of health care products, and more specifically relates to a tea drink with anti-alcohol and liver-protecting effects and a preparation method thereof.
With the continuous improvement of people's living standards, the number and quantity of drinkers in China are on the rise, although a small amount of drinking can promote blood circulation, dredge collaterals and dispel cold, adjust mood and eliminate fatigue and tension;
However, excessive drinking and excessive drinking will cause pathological damage to many tissues and organs including cardiovascular system, nervous system and digestive system, and even lead to death due to respiratory muscle paralysis in severe cases. Investigation shows that among patients who drink alcohol for a long time, about 57.5% patients have fatty liver and 15% patients have cirrhosis. With the increase of alcohol consumption and the extension of drinking time, the harm of alcohol to the liver gradually develops according to the trilogy of "alcoholic fatty liver, alcoholic hepatitis and alcoholic cirrhosis". By affecting the metabolism of the liver, the lipid components on the surface of the hepatocyte membrane are over-oxidized, thus damaging the hepatocyte membrane and leading to the destruction of hepatocytes. This process is an important link for alcohol to damage the liver.
Therefore, it is an urgent problem for technicians in this field to develop a tea with obvious efficacy, long-term consumption, anti-alcohol and liver-protecting effects and its preparation method.
SUMMARY LU504233
In view of this, the invention provides a tea which has obvious efficacy, can be consumed for a long time, and has the efficacy of anti-alcohol and liver-protecting, and a preparation method thereof.
In order to achieve the above purpose, the invention adopts the following technical scheme:
A tea drink with anti-alcohol and liver-protecting effects comprises the following raw materials in parts by weight: 3-4 parts of Hovenia dulcis, 1-2 parts of Pueraria lobata, 1-2 parts of mulberries, 1-2 parts of chrysanthemum, 1-2 parts of Pericarpium citri reticulatae and 1-3 parts of Pu-er ripe tea.
The invention has the beneficial effects that according to the theory of Traditional Chinese
Medicine Formulation, the Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum and
Pericarpium citri reticulatae, which are homologous in medicine and food, are compounded to prepare a tea with the efficacy of anti-alcohol and liver-protecting, which not only has excellent performance in sensory quality, such as color, taste and fragrance, but also increases the enjoyment of the tea drink; Experiments are carried out in zebrafish, a model organism, which shows that the tea of the invention has obvious efficacy, and people can achieve the effect of anti-alcohol and liver-protecting after taking it for a long time, so it is suitable for popularization and application.
In addition, the effective components in Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae and other plant sources, which are homologous to medicine and food, have good medicinal functions of anti-alcohol and liver-protecting.
Hovenia dulcis contains loline and Hovenin, which has the effects of promoting diuresis, reducing swelling and anti-alcohol.
Pueraria lobata, as prescribed in China Pharmacopoeia 2015, is sweet, pungent and cool.
Concerning spleen, stomach and lung meridians. Able to relieve muscle and fever, promote fluid production to quench thirst, penetrate rash, raise yang to stop diarrhea, dredge channels and activate collaterals, and relieve alcoholism. It can be used for treating exogenous fever, headache, strong nape pain, thirst-quenching, measles, dysentery, diarrhea, dizziness, stroke, hemiplegia, chest obstruction, heartache, and alcoholic injury.
Mulberries are warm and sweet, and has the functions of nourishing liver and kidney/°04233 nourishing blood and promoting fluid production;
Chrysanthemum 1s rich in volatile oil, flavonoids, amino acids and other components. It can dilate the coronary artery, increase the arterial blood flow and improve the tolerance of myocardial cells to hypoxia;
Pericarpium citri reticulatae is rich in volatile oil, which can cure stomach Qi rising, nausea and vomiting.
According to the invention, medicinal and edible raw materials are selected, and through scientific dialectical compatibility and mutual coordination, the efficacy of the composition in anti-alcohol and liver-protecting is jointly promoted. In the composition of the invention,
Hovenia dulcis, Pueraria lobata and mulberries are used as components for resisting oxidation, liver-protecting and anti-alcohol, while Pericarpium citri reticulatae, chrysanthemum and Pu-er ripe tea are used as components for assisting in liver-protecting and anti-alcohol and adjusting flavor, and through compounding and synergism, the efficacy of anti-alcohol and liver-protecting of the composition is jointly promoted, so that the composition with good effect of anti-alcohol and liver-protecting is obtained.
In addition, in the prior art, although the common dosage of each Chinese medicine is known, the prescription is an organic whole after compatibility of multiple medicines according to the symptoms, and its efficacy is not equal to the simple superposition of each medicine on the basis of the common dosage. According to the common dosage of each Chinese medicine, the dosage in the prescription is usually not determined, and the dosage ratio of the medicine is determined by various considerations such as the characteristics of the medicine, the theory of
Traditional Chinese Medicine Formulation, and so on, and it is not simply optimized by experimental means such as comparative method and orthogonal method.
The invention also provides a preparation method of the tea drink with anti-alcohol and liver-protecting effects, which comprises the following steps: (1) Weigh the raw materials according to the described tea drink with anti-alcohol and liver-protecting effects; (2) Mix Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae and Pu-er ripe tea, put them into an extraction tank, add hot water for extraction, and then add mulberries for continuous extraction to obtain a mixture; LU504233 (3) Centrifuge the mixture, collect supernatant, concentrate and dry to obtain the tea.
The invention has the beneficial effects of simple preparation method, convenient operation and suitability for large-scale production and application.
Furthermore, in step (2), the temperature of the hot water is 95°C.
The adoption of the further technical scheme has the beneficial effects that by adding hot water for extraction, some components insoluble in cold water can be fully extracted in a limited time.
Furthermore, in step (2), hot water is added for extraction, the temperature of the extraction tank is 90-95°C, and the extraction time is 1h.
The adoption of the further technical scheme has the beneficial effects that the extraction process selected by the invention can better extract effective components and exert the maximum efficacy.
Furthermore, in step (2), mulberries are added and the extraction is continued, and the temperature of the extraction tank is 90-95°C, and the extraction time is 30min.
The adoption of the further technical scheme has the beneficial effects that the selected extraction process can better maintain the nutritional value of the mulberries, and at the same time, the original taste and color of the mulberries can be avoided from being changed due to too long extraction time.
Furthermore, in step (3), the centrifugal speed is 19000rpm and the centrifugal time is 2.5h.
The adoption of the above further technical scheme has the beneficial effects that higher rotating speed can make the tea soup color clearer, and long-term centrifugation can keep the materials slowly entering the centrifuge, so that the impurities in it can be fully separated.
Furthermore, in step (3), the above concentration is carried out by using low-temperature reverse osmosis membrane, the concentration temperature is 25-35°C, the concentration time is 2h, and the concentration of the concentrated solution is 9.4%.
The adoption of the further technical scheme has the beneficial effects that the original taste and nutritional value of the materials can be better maintained through concentration.
Furthermore, in step (3), the drying temperature is 156°C and the drying time is 8h.
The adoption of the further technical scheme has the beneficial effects that the moisture hp 904233 the material is more likely to volatilize in a high-temperature environment to form powder, and the drying time can be controlled so that the material can slowly enter the spray drier and the dryness of the powder can be maintained.
Furthermore, it also includes step (4): making the tea into powder, granule, pill or tablet.
The adoption of the above further technical scheme has the beneficial effects that it can be carried and consumed more conveniently.
The invention also provides an application of the tea drink with anti-alcohol and liver-protecting effects in preparing health food.
In order to clearly explain the embodiment of the present invention or the technical scheme in the prior art, the figures needed in the description of the embodiment or the prior art will be briefly introduced below. Obviously, the figures in the following description are only the embodiment of the present invention, and other figures can be obtained according to the provided figures without creative labor for ordinary people in the field.
Fig. 1 is a typical diagram of zebrafish behavior track after tea treatment (black line: slow movement; gray line: fast movement; the rest: medium-speed movement)
Fig. 2 is a comparison diagram of the total movement distance of zebrafish after tea treatment of the present invention and the model control group, **p<0.01, ***p<0.001.
Fig. 3 is a diagram of the anti-alcohol effect of the tea of the present invention.
Fig. 4 is a typical diagram of the liver fat staining intensity of zebrafish after tea treatment of the present invention.
Fig. 5 is a comparison diagram of the liver fat staining intensity of zebrafish after tea treatment of the present invention and the model control group, ***p<0.001.
Fig. 6 is a diagram showing the protective effect of the tea of the present invention on alcoholic fatty liver.
DETAILED DESCRIPTION OF THE INVENTION 0504238
The technical scheme in the embodiment of the present invention will be described clearly and completely below. Obviously, the described embodiment is only a part of the embodiment of the present invention, but not the whole embodiment. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in the field without creative labor belong to the scope of protection of the present invention.
Embodiment 1
The preparation method of the tea drink with anti-alcohol and liver-protecting effects comprises the following steps: (1) Weigh 4kg of Hovenia dulcis, 2kg of Pueraria lobata, 1kg of mulberries, 1kg of chrysanthemum, 1kg of Pericarpium citri reticulatae and 3kg of Pu-er ripe tea; (2) Mix Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae and Pu-er ripe tea, put them into an extraction tank, add 95°C hot water for extraction for 1h, the temperature of the extraction tank is 95 °C, then add mulberries for continuous extraction for 30min, the temperature of the extraction tank is 95 °C, afterwards, obtain the mixture; (3) Centrifuge the mixture at the speed of 19000rpm for 2.5h, take the supernatant, concentrate it for 2h with low-temperature reverse osmosis membrane at 25°C until the concentration of the concentrated solution is 9.4%, and dry it at 156°C for 8h to obtain the tea drink.
Embodiment 2
The preparation method of the tea drink with anti-alcohol and liver-protecting effects comprises the following steps: (1) Weigh 3kg of Hovenia dulcis, 1kg of Pueraria lobata, 2kg of mulberries, 1kg of chrysanthemum, 2kg of Pericarpium citri reticulatae and 1kg of Pu-er ripe tea; (2) Mix Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae and Pu-er ripe tea, put them into an extraction tank, add 95°C hot water for extraction for 1h, the temperature of the extraction tank is 90 °C, then add mulberries for continuous extraction for 30min, the temperature of the extraction tank is 90 °C, afterwards, obtain the mixture;
(3) Centrifuge the mixture at the speed of 19000rpm for 2.5h, take the supernatarit) 204233 concentrate it for 2h with low-temperature reverse osmosis membrane at 35°C until the concentration of the concentrated solution is 9.4%, and dry it at 156°C for 8h to obtain the tea drink.
Embodiment 3
The preparation method of the tea drink with anti-alcohol and liver-protecting effects comprises the following steps: (1) Weigh 3kg of Hovenia dulcis, 1kg of Pueraria lobata, 2kg of mulberries, 1kg of chrysanthemum, 1kg of Pericarpium citri reticulatae and 2kg of Pu-er ripe tea; (2) Mix Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae and Pu-er ripe tea, put them into an extraction tank, add 95°C hot water for extraction for 1h, the temperature of the extraction tank is 92 °C, then add mulberries for continuous extraction for 30min, the temperature of the extraction tank is 92 °C, afterwards, obtain the mixture; (3) Centrifuge the mixture at the speed of 19000rpm for 2.5h, take the supernatant, concentrate it for 2h with low-temperature reverse osmosis membrane at 30°C until the concentration of the concentrated solution is 9.4%, and dry it at 156°C for 8h to obtain the tea drink.
In the following experiments, the Pueraria lobata Hovenia dulcis tea refers to the tea of the embodiment of the invention.
Experiment 1 of Pueraria lobata Hovenia dulcis tea: Experiment on anti-alcohol effect 300 Sdpf wild-type AB strain zebrafish are randomly selected in a six-well plate, and treat zebrafish in each experimental group, and then give them ethanol in water to establish a drunken model of zebrafish during the exciting period. The concentrations of Pueraria lobata
Hovenia dulcis tea in Embodiment 3 are 78.1, 156.3, 312.5, 625, 1250, 2500 and 5000pug/mL respectively, and the positive control group "Ru21" is 100ug/mL. At the same time, the normal control group and the model control group are set up, and the capacity of each well is 3ml. After the treatment: 1) Observe and count the number of zebrafish deaths and toxic reactions in each experimental group, and determine the maximum test concentration (MTC) of Pueraria lobata
Hovenia dulcis tea; 2) Three concentration groups (MTC and below), positive control group,
model control group and normal control group are selected, and 12 zebrafish are randomly’ 504233 selected from each group. The total movement distance (S) of zebrafish is analyzed with the detection software of behavior analyzer, and the anti-alcohol effect of Pueraria lobata Hovenia dulcis tea is evaluated with the statistical analysis results of the total movement distance. The statistical results are expressed by mean+SE. The formula of anti-alcohol effect is as follows:
Statistical analysis is made by variance analysis and Dunnett'sT- ST-test, p<0.05 means that there is significant difference.
Table 1 Experimental Results of Anti-alcohol Concentration of Pueraria lobata Hovenia dulcis Tea (n = 30)
Under the experimental conditions, the MTC of Pueraria lobata Hovenia dulcis Tea is 2500ug/mL.
Table 2 Total Movement Distance of Zebrafish Treated with Pueraria lobata Hovenia dulcis
Tea (n= 12)
Compared with the model control group, **p<0.01, ***p<0.001.
Table 2 shows that Pueraria lobata Hovenia dulcis Tea has remarkable anti-alcohol effect.
Experiment 2: Protective effect test of alcoholic fatty liver
Randomly select 270 Sdpf melanin allele mutated semi transparent Albino strains of zebrafish in a six well plate, and 30 zebrafish are treated in each experimental group. The model of alcoholic fatty liver of zebrafish is established by dissolving in water and giving ethanol. The concentrations of Pueraria lobata Hovenia dulcis Tea in Embodiment 3 are 78.1, 156.3, 312.5, 625, 1250, 2500 and 5000pg/mL, respectively. At the same time, the normal control group and the model control group are set up, and the capacity of each well is 3ml. After the treatment: 1)
Observe and count the number of zebrafish deaths and toxic reactions in each experimental group, and determine the MTC of Pueraria lobata Hovenia dulcis Tea, 2) Take three concentration groups (MTC and below), positive control group, model control group and norma’ 204233 control group, and randomly select 10 zebrafish in each group to take photos under dissecting microscope, analyze and collect data with NIS-ElementsD3.10 advanced image processing software, and analyze the intensity (S) of liver fat staining of zebrafish, and evaluate the protective effect of Pueraria lobata Hovenia dulcis Tea on alcoholic fatty liver with the statistical analysis results of liver fat staining intensity. The statistical results are expressed by mean+SE.
The formula for calculating the protective effect of alcoholic fatty liver is as follows:
Statistical analysis is made by variance analysis and Dunnett'sT- ST-test, p<0.05 means that there is significant difference.
Table 3 Experimental Results of Protective Concentration of Pueraria lobata Hovenia dulcis Tea on Alcoholic Fatty Liver (n = 30)
Under the experimental conditions, the MTC of Pueraria lobata Hovenia dulcis tea is 2500ug/mL.
Table 4 The Intensity of Fat Staining in The Liver of Zebrafish Treated with Pueraria lobata Hovenia dulcis Tea (n = 10)
Compared with the model control group, ***p<0.001.
Table 4 shows that Pueraria lobata Hovenia dulcis Tea has a significant protective effect on alcoholic fatty liver.
The description of the disclosed embodiments enables those skilled in the art to make or use the invention. Many modifications to these embodiments will be obvious to those skilled in the art, and the general principles defined herein can be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the present invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. A tea drink with anti-alcohol and liver-protecting effects, which is characterized by comprising the following raw materials in parts by weight: 3-4 parts of Hovenia dulcis, 1-2 parts of Pueraria lobata, 1-2 parts of mulberries, 1-2 parts of chrysanthemum, 1-2 parts of Pericarpium citri reticulatae and 1-3 parts of Pu-er ripe tea.
2. A method for preparing the tea drink with anti-alcohol and liver-protecting effects, which comprises the following steps: (1) weigh the raw materials of the tea drink with anti-alcohol and liver-protecting effects according to claim 1; (2) mix Hovenia dulcis, Pueraria lobata, mulberries, chrysanthemum, Pericarpium citri reticulatae and Pu-er ripe tea, put them into an extraction tank, add hot water for extraction, and then add mulberries for continuous extraction to obtain a mixture: (3) centrifuge the mixture, collect supernatant, concentrate and dry to obtain the tea.
3. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that in step (2), the temperature of the hot water is 95°C.
4. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that in step (2), 95°C hot water is added for extraction, the extraction tank temperature is 90-95°C, and the extraction time 1s 1h.
5. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that in step (2), mulberries are added to continue extraction, the extraction tank temperature is 90-95°C, and the extraction time is 30min.
6. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that in step (3), the centrifugal speed is 19000rpm and the centrifugal time is 2.5h.
7. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that in step (3), low-temperature reverse osmosis membrane concentration is adopted, the concentration temperature is 25-35°C, the concentration time is 2h, and the concentration of concentrated solution is 9.4%.
8. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that in step (3), the drying temperature is 156°C and the drying time is 8h. LU504233
9. The preparation method of tea drink with anti-alcohol and liver-protecting effects according to claim 2, characterized in that it further comprises step (4): making the tea into powder, granules, pills or tablets.
10. An application of the tea drink with anti-alcohol and liver-protecting effects as claimed in claim 1 in preparing health food.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU504233A LU504233B1 (en) | 2023-05-16 | 2023-05-16 | A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method Thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU504233A LU504233B1 (en) | 2023-05-16 | 2023-05-16 | A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method Thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
LU504233B1 true LU504233B1 (en) | 2023-11-16 |
Family
ID=88838651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU504233A LU504233B1 (en) | 2023-05-16 | 2023-05-16 | A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method Thereof |
Country Status (1)
Country | Link |
---|---|
LU (1) | LU504233B1 (en) |
-
2023
- 2023-05-16 LU LU504233A patent/LU504233B1/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103740566B (en) | Rosa roxbunghii medicinal liquor and preparation method thereof | |
WO2022116807A1 (en) | Method for preparing ganoderma lucidum extract oil rich in ganoderma lucidum triterpene | |
CN106244371A (en) | A kind of blood sugar lowering Rhizoma Polygonati grape health care wine and production technology thereof | |
CN104877876A (en) | Mulberry black rice wine and making method thereof | |
CN106265254A (en) | The Tricholoma matsutake (lto et lmai) Singer extract and its preparation method and application of skin can be repaired by whitening skin and preserving moisture | |
CN111134262A (en) | Traditional Chinese medicine solid anti-alcohol beverage and preparation method thereof | |
CN112931652A (en) | Making process of dried orange peel golden flower strip-shaped black tea with blood sugar reducing effect | |
CN101991165A (en) | Sweet potato leaf-perilla leaf composite beverage and preparation method thereof | |
CN102260617B (en) | Royal jelly specially-produced wine and preparation technology thereof | |
LU504233B1 (en) | A Tea Drink with Anti-Alcohol and Liver-Protecting Effects and Preparation Method Thereof | |
CN111592959A (en) | Tonic three-penis wine and extraction method thereof | |
CN113813313A (en) | Tea beverage with effects of dispelling effects of alcohol and protecting liver and preparation method thereof | |
CN110923101A (en) | Processing method of six-ingredient rehmannia health wine | |
CN109287919A (en) | A kind of formula and preparation method of red bean adlay draft cream | |
CN111493253A (en) | Preparation method of dendrobium officinale beverage | |
CN113201427A (en) | Processing method of health-care wine containing wolfberry, chrysanthemum and rehmannia | |
CN109418763A (en) | A kind of Jasmine donkey-hide gelatin and preparation method thereof | |
CN103039866A (en) | Soybean meal with functions of nourishing kidney and liver and preparation method | |
CN103484301B (en) | Fruit wine containing Chinese chestnut and potato and production method thereof | |
CN105961682A (en) | Method for preparing tea for relieving effect of alcohol and nourishing liver | |
CN110652547A (en) | Body-strengthening and lipid-lowering tea and preparation method thereof | |
CN110547381A (en) | Preparation method of papaya enzyme compound beverage | |
CN105535032A (en) | Extraction method of truffle polysaccharides and health-care truffle product | |
CN105936850A (en) | Anti-aging wine with beauty maintaining and young keeping functions | |
CN110240995A (en) | A kind of bitter buckwheat red yeast rice medlar health preserving vinegar and its production technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Effective date: 20231116 |